CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.

MLA

Lista, Simone, et al. “CSF Aβ1-42 Combined with Neuroimaging Biomarkers in the Early Detection, Diagnosis and Prediction of Alzheimer’s Disease.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, vol. 10, no. 3, May 2014, pp. 381–92. EBSCOhost, https://doi.org/10.1016/j.jalz.2013.04.506.

APA

Lista, S., Garaci, F. G., Ewers, M., Teipel, S., Zetterberg, H., Blennow, K., & Hampel, H. (2014). CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer’s disease. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 10(3), 381–392. https://doi.org/10.1016/j.jalz.2013.04.506

Chicago

Lista, Simone, Francesco G Garaci, Michael Ewers, Stefan Teipel, Henrik Zetterberg, Kaj Blennow, and Harald Hampel. 2014. “CSF Aβ1-42 Combined with Neuroimaging Biomarkers in the Early Detection, Diagnosis and Prediction of Alzheimer’s Disease.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association 10 (3): 381–92. doi:10.1016/j.jalz.2013.04.506.